Skip to main content

Advertisement

SpringerLink
Log in

The multiple sclerosis market

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Shifting composition for the multiple sclerosis market.

References

  1. Yong, V. W. et al. Interferon β in the treatment of multiple sclerosis: mechanisms of action. Neurology 51, 682–689 (1998).

    Article  CAS  Google Scholar 

  2. Copaxone. Copaxone prescribing information. Copaxone website, [online] (2010).

  3. National Institute for Health and Clinical Excellence. Multiple sclerosis — β interferon and glatiramer acetate. NICE website, [online] (2002).

  4. Boggild, M. et al. Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator. BMJ 339, b4677 (2009).

    Article  Google Scholar 

  5. Novartis. Two-year Phase III study shows Novartis oral MS therapy FTY720 significantly reduces relapses and disability progression. Novartis website, [online] (2009).

  6. The CAMMS223 trial investigators. Alemtuzumab vs. interferon β-1a in early multiple sclerosis. N. Engl. J. Med. 359, 1786–1801 (2008).

  7. Wynn, D. et al. Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon β. Lancet Neurol. 9, 381–390 (2010).

    Article  CAS  Google Scholar 

  8. Datamonitor. Commercial insight: multiple sclerosis — next generation therapies signal the start of a new era. (Datamonitor, 2010).

Download references

Author information

Authors and Affiliations

  1. Trung Huynh, Ph.d., is an analyst at Datamonitor, 119 Farringdon Road, London EC1R 3DA, UK. THuynh@Datamonitor.com,

    Trung Huynh

Authors
  1. Trung Huynh
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huynh, T. The multiple sclerosis market. Nat Rev Drug Discov 9, 759–760 (2010). https://doi.org/10.1038/nrd3272

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3272

  • Springer Nature Limited

Search

Navigation